Results 1 to 10 of about 24,596 (232)

Detection of OXA-23 and OXA-58 in Proteus mirabilis by immunochromatographic assays [PDF]

open access: yesMicrobiology Spectrum
Proteus mirabilis is increasingly recognized as a carrier of carbapenemases, which are particularly difficult to identify, since most isolates have low carbapenem MICs. Additionally, most phenotypic tests (e.g.
Janina Noster-Schrader   +7 more
doaj   +2 more sources

Carriage of K. pneumoniae and molecular structure of produced carbapenemases in infants with congenital heart defects [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2023
Objective. To evaluate frequency of pharyngeal and rectal mucosa colonization by K. pneumoniae strains in infants with congenital heart defects at the stage of cardiosurgical hospital admission, as well as dynamic analysis of production frequency and ...
Popov D.A.   +2 more
doaj   +1 more source

Expression analysis of drug-resistant gene (blaOXA-51) in carbapenemases producing Acinetobacter baumannii treated with imipenem/sulbactam combination

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2021
Drug-resistant Acinetobacter baumannii is a frightening reality. The aim of this study is to examine the expression profiles of blaOXA-51 gene in carbapenemases producing A. baumannii treated with imipenem/sulbactam combination.
Saber Noshadi, Alireza Khodavandi
doaj   +1 more source

Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales

open access: yesFrontiers in Medicine, 2021
Gram-negative bacteria, especially Enterobacterales, have emerged as major players in antimicrobial resistance worldwide. Resistance may affect all major classes of anti-gram-negative agents, becoming multidrug resistant or even pan-drug resistant ...
Rémy A. Bonnin   +20 more
doaj   +1 more source

Carbapenemases as factors of Resistance to Antibacterial Drugs

open access: yesActa Biomedica Scientifica, 2021
Antibiotic drugs are used to treat and prevent bacterial infections around the world. The emergence and spread of  bacterial resistance to carbapenems is currently a real threat that determines the need for its timely detection and  suppression ...
A. V. Nevezhina
doaj   +1 more source

Evaluation of Xpert Carba-R for detecting carbapenemase-producing organisms in South Africa

open access: yesAfrican Journal of Laboratory Medicine, 2023
This study evaluated the performance of the Xpert Carba-R assay for detecting the five common carbapenemases in carbapenemase-producing organisms in Johannesburg, South Africa between April 2021 and September 2021.
Sanelisiwe T. Duze   +5 more
doaj   +1 more source

Comparative Activity of Carbapenem Antibiotics Against Gram-Negative Carbapenemase Producers of Different Groups

open access: yesАнтибиотики и Химиотерапия, 2022
The rapid spread of gram-negative bacteria resistance to carbapenems due to the production of carbapenemases requires new treatment options. The activity of carbapenem antibiotic biapenem, recently registered in Russia, against producers of various ...
V. A. Ageevets   +9 more
doaj   +1 more source

In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018

open access: yesJournal of Global Antimicrobial Resistance, 2021
: Objectives: This study reports the antimicrobial activity of ceftazidime/avibactam (CZA) and comparators against carbapenemase-producing Enterobacterales (N = 1992) and carbapenemase-producing Pseudomonas aeruginosa (N = 784) collected in Africa/Middle
Pattarachai Kiratisin   +2 more
doaj   +1 more source

Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization

open access: yesАнтибиотики и Химиотерапия, 2020
The resistance of Enterobacterales to carbapenems can be realized by different mechanisms, but the most common one is enzymatic, associated with the production of carbapenemases.
S. V. Yakovlev   +2 more
doaj   +1 more source

Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report [PDF]

open access: yes, 2016
Transplant recipients are at high risk of infections caused by multidrug resistant microorganisms. Due to the limited thera- peutic options, innovative antimicrobial combinations against carbape- nem-resistant Enterobacteriaceae causing severe infections
CIPOLLA, ALESSIA   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy